An observational study investigating the safety, tolerability and health outcomes of cannabinoid therapy prescribed to eligible patients for management of recognized chronic conditions

Not Applicable

• Conditions: Chronic Pain; Anxiety; Insomnia; Any recognized condition for which medicinal cannabis could be prescribed for; Post-traumatic stress disorder; Dementia; Parkinson's disease/Tremor; Seizure management/Epilepsy; Neuropathic pain; Mood Disorder

• Registration Number: ACTRN12623000149662
• Lead Sponsor: Cloud Medical PTY LTD

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-02-15
• Last Update Posted: 6 March 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

1. Prospective participants must be greater than to equal to 18 years of age at time of entry on study
2. Prospective participants must be willing and able to understand the informed consent process, provide informed consent, and participate in the observational study
3. Prospective participants must be eligible to be lawfully prescribed cannabinoid therapy by their Physician
4. Prospective participants agree to abstain from using cannabinoid therapy other than the therapy that is prescribed by their Physician

Exclusion Criteria

1. Prospective participants are ineligible if they are under the age of 18
2. Prospective participants are ineligible if they are unwilling, unable or cannot understand the informed consent form
3. Prospective participants are ineligible if their Physician determines that the prospective participant is unable to fulfill any requirements of the study
4. Prospective participants are ineligible if they are currently using illicit drugs and/or with alcohol abuse.
5. Prospective patients are ineligible if any of the following are met:
5.1. Have an active or previous psychotic or active mood or anxiety disorder
5.2. Women who are pregnant, planning to become pregnant or breastfeeding
5.3. Have unstable cardiovascular disease

Study & Design

• Study Type: Observational
• Study Design: Not specified